Clinical Trials Logo

Clinical Trial Summary

The goal of this observational study is to compare the tongue bioinformatics of high-risk and low-risk patients with esophageal varices due to liver cirrhosis. The main question of this study is to explore whether there exists a relationship between the degree of esophageal varices and tongue bioinformatics in liver cirrhosis. it aims to answer 2 questions as below: question 1: If these is a significant difference in tongue bioinformatics between patients in liver cirrhosis with high-risk and low-risk of esophageal varices. Question 2; If tongue bioinformatics can be used as a diagnostic basic for testing esophageal varices in liver cirrhosis. Firstly, participants will be divided into two groups according to their degree of esophageal varices from electronic gastroscopy report and CT scan report including high-risk group and low-risk group. Secondly, participants will be asked to show their tongue, including the surface and sublingual veins of tongue, and the tongue images of each participants will be collected by researchers via camera. After finishing tongue image collection, participants will receive a professional tongue diagnosis report in Traditional Chinese Medicine and health suggestion.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05979935
Study type Observational [Patient Registry]
Source Qilu Hospital of Shandong University
Contact
Status Active, not recruiting
Phase
Start date July 1, 2023
Completion date April 2024

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05055713 - A Randomized Controlled Study on the Treatment of Cirrhosis Combined With Hypersplenism N/A
Recruiting NCT02945930 - Study the Safety and Efficacy of "Compont Medical Glue" in the Treatment of Esophagogastric Varices N/A
Completed NCT04823780 - The Effects of Early Enteral Nutrition on Endoscopic Therapy of Esophagogastric Varices in Liver Cirrhosis
Completed NCT03244332 - HEMOCC Study. Hemostasis in Cirrhotic Children. N/A
Completed NCT02991612 - Rifaximin in Patients With Gastroesophageal Variceal Bleeding N/A
Recruiting NCT02964195 - Efficacy of Rifaximin in Treatment of Cirrhotic Gastroesophageal Variceal Bleeding N/A
Completed NCT00004641 - A Study to Prevent Complications of High Blood Pressure Caused by Hepatitis in Patients With Cirrhosis Phase 2
Completed NCT02593799 - Non-invasive Prediction of Esophageal Varices in Liver Cirrhosis: A Multicenter Observational Study
Recruiting NCT02719119 - Trial of Monthly Versus Bi-weekly Endoscopic Variceal Ligation for the Prevention of Esophageal Variceal Rebleeding N/A
Recruiting NCT02385422 - The Effect of Carvedilol Vs Propranolol in Cirrhotic Patients With Variceal Bleeding Phase 4
Completed NCT00838864 - Comparison of 3 Days and 7 Days Intravenous Ceftriaxone Prophylaxis for Variceal Bleeding Phase 4
Not yet recruiting NCT03130127 - Continuous Versus Bolus Infusion of Terlipressin for Portal Hypertension Related Bleeding in Liver Cirrhosis N/A
Recruiting NCT02504723 - Carvedilol as an Adjunct to Endoscopic Cyanoacrylate Injection for Secondary Prophylaxis of Gastric Variceal Bleeding Phase 4
Withdrawn NCT00475592 - Validation of Esophageal Variceal Grading: A Comparative Study of Upper Gastrointestinal (GI) Endoscopy and Capsule Endoscopy N/A
Completed NCT05331768 - Comparison of Endoscopic Band Ligation Plus 24-hour Versus 72-hour Terlipressin Therapy N/A
Completed NCT04210297 - Development and Validation of an Noninvasive Model for Predicting High Risk Esophageal Varices in Cirrhosis
Recruiting NCT02311608 - Effects of Terlipressin When Usual Somatostatin or Octreotide Dose Fails N/A
Completed NCT04976543 - Safety of Anticoagulant Therapy After Endoscopic Treatment Phase 4
Not yet recruiting NCT05978752 - Clinical Study on Endoscopic Management of GOV1 Esophagogastric Varices N/A
Recruiting NCT02695732 - The Effect of Carvedilol VS Endoscopic Therapy in Primary Prophylaxis of High-risk Esophageal Gastric Variceal Bleeding Phase 4